Key facts
- This page summarizes Chen Schor's Form 4 filing for Adicet Bio, Inc. (ACET).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Jan 2024, 19:06.
Chen Schor - 24 Jan 2024 Form 4 Insider Report for Adicet Bio, Inc. (ACET)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- ACET
- Reported as of
- 24 Jan 2024
- Net transaction value
- -$36,696
- SEC form
- 4
- Accepted by SEC
- 26 Jan 2024, 19:06:45 UTC
- Prior SEC filing
- 02 Oct 2023
- Next SEC filing
- 30 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Harvey, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chen Schor filed Form 4 for Adicet Bio, Inc. (ACET) on 26 Jan 2024.
Change
- Previous filing in this sequence was filed on 02 Oct 2023.
- Current net transaction value: -$36,696.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACET
transaction
Common Stock
Tax liability
- Transaction value
- $36,696
- Shares
- -15,290
- Change %
- -9.9%
- Price
- $2.40
- Shares after
- 138,471
- Date
- 24 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
ACET
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +70,300
- Change %
- +51%
- Price
- $0.000000
- Shares after
- 208,771
- Date
- 24 Jan 2024
- Ownership
- Direct
- Footnotes
- F2
ACET
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 43,469
- Date
- 24 Jan 2024
- Ownership
- See Footnote
- Footnotes
- F3
ACET
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 53,424
- Date
- 24 Jan 2024
- Ownership
- See Footnote
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACET
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,116,903
- Change %
- Price
- $0.000000
- Shares after
- 1,116,903
- Date
- 24 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,116,903
- Exercise price
- $2.40
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
Footnote F2
The Reporting Person was issued RSUs. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2025. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
Footnote F3
Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
Footnote F4
Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
Footnote F5
1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.